Treatment of Malignant Tumors With NK Cell
Condition(s):MalignancyLast Updated:December 3, 2021Unknown status
Hide Studies Not Open or Pending
Condition(s):MalignancyLast Updated:December 3, 2021Unknown status
Condition(s):Acute Myeloid LeukemiaLast Updated:February 27, 2023Recruiting
Condition(s):Safety and EfficacyLast Updated:January 13, 2023Terminated
Condition(s):NK Cell Mediated Immunity; EndometriosisLast Updated:May 14, 2019Unknown status
Condition(s):Diffuse Large B Cell LymphomaLast Updated:August 28, 2023Recruiting
Condition(s):Autoimmune DiseasesLast Updated:March 25, 2024Recruiting
Condition(s):Acute Myeloid LeukemiaLast Updated:February 17, 2023Recruiting
Condition(s):NK Cell; B-cell Lymphoma Recurrent; B-cell Lymphoma RefractoryLast Updated:June 22, 2023Not yet recruiting
Condition(s):Multiple Myeloma; Plasma Cell LeukemiaLast Updated:September 21, 2023Recruiting
Condition(s):Systemic Lupus Erythematosus (SLE)Last Updated:March 25, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.